JPRN-UMIN000011500
Completed
Phase 1
Brachytherapy using linked-seed for prostate cancer with one intermediate risk factor -multicenter phase I/II trial- - Linked-seed brachytherapy for prostate cancer with one intermediate risk factor
Osaka University Graduate School of Medicine, Radiation Oncology0 sites25 target enrollmentAugust 16, 2013
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Osaka University Graduate School of Medicine, Radiation Oncology
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) active other cancer 2\) uncontrollable diabetes millitus 3\) ubable to stop anticoagulation drug 4\) significant psycologic disease 5\) collagen disease 6\) judged as inappropriate by the dedicated physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Focal Brachytherapy for localized prostate cancer diagnosed by saturation biopsyJPRN-UMIN000044790ara Medical University35
Recruiting
Phase 2
Salvage focal therapy for prostate cancer using low-dose-rate brachytherapyprostate cancerJPRN-UMIN000051113Saitama Cancer Center100
Recruiting
Phase 2
Primary focal therapy for prostate cancer using low-dose-rate brachytherapyprostate cancerJPRN-UMIN000050997Saitama Cancer Center200
Completed
Not Applicable
Focal therapy of localized prostate cancer using mpMRI/TRUS-guided high intensity focused ultrasound (HIFU) technologyC61Malignant neoplasm of prostateDRKS00007105Klinik für Urologie, Universitätsmedizin Mannheim50
Completed
Not Applicable
Implantation of marker seeds into the prostate; to improve quality of radiotherapy delivery and to allow dose escalation for men with localised prostate cancerocalised prostate cancer in men.Inter-fraction prostate motion and motion of prostate relative to its position at simulation are potential sources of systematic treatment error.Localised prostate cancer in men.Inter-fraction prostate motion and motion of prostate relative to its position at simulation are potential sources of systematic treatment error.Cancer - ProstateACTRN12607000335493Dr George Hruby20